63 related articles for article (PubMed ID: 1665648)
1. [Two-dimensional electrophoretic analysis of the protein spectrum of human brain structures in schizophrenia and senile dementia of the Alzheimer type].
Smirnov AV; Shevtsov PN; Burbaeva GSh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):34-6. PubMed ID: 1665648
[TBL] [Abstract][Full Text] [Related]
2. [Decreased level of creatine phosphokinase BB in the brain of patients with mental disorders (complex immunochemical and immunocytochemical studies)].
Burbaeva GSh; Aksenova MV; Makarenko IG; Kalinenko OO
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(10):49-52. PubMed ID: 1962998
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
Kanninen K; Goldsteins G; Auriola S; Alafuzoff I; Koistinaho J
Neurosci Lett; 2004 Sep; 367(2):235-40. PubMed ID: 15331161
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
5. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
[TBL] [Abstract][Full Text] [Related]
6. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
[TBL] [Abstract][Full Text] [Related]
7. Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles.
Harpin ML; Delaère P; Javoy-Agid F; Bock E; Jacque C; Delpech B; Villarroya H; Duyckaerts C; Hauw JJ; Baumann N
J Neurosci Res; 1990 Dec; 27(4):587-94. PubMed ID: 2079719
[TBL] [Abstract][Full Text] [Related]
8. Protein oxidation in the brain in Alzheimer's disease.
Aksenov MY; Aksenova MV; Butterfield DA; Geddes JW; Markesbery WR
Neuroscience; 2001; 103(2):373-83. PubMed ID: 11246152
[TBL] [Abstract][Full Text] [Related]
9. [BB creatine phosphokinase activity and content of the brain structures in senile dementia and Alzheimer's diseases].
Burbaeva GSh; Aksenova MV; Bibikova VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1374-8. PubMed ID: 3321799
[TBL] [Abstract][Full Text] [Related]
10. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
[TBL] [Abstract][Full Text] [Related]
11. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
Ferrer I; Perez E; Dalfó E; Barrachina M
Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease.
Riederer IM; Schiffrin M; Kövari E; Bouras C; Riederer BM
Brain Res Bull; 2009 Oct; 80(4-5):233-41. PubMed ID: 19427371
[TBL] [Abstract][Full Text] [Related]
13. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis.
Sizova D; Charbaut E; Delalande F; Poirier F; High AA; Parker F; Van Dorsselaer A; Duchesne M; Diu-Hercend A
Neurobiol Aging; 2007 Mar; 28(3):357-70. PubMed ID: 16519965
[TBL] [Abstract][Full Text] [Related]
15. [Physiologically active brain proteins as possible markers of mental diseases].
Burbaeva GSh
Vestn Ross Akad Med Nauk; 1992; (7):51-4. PubMed ID: 1281711
[TBL] [Abstract][Full Text] [Related]
16. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
Greber S; Lubec G; Cairns N; Fountoulakis M
Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
[TBL] [Abstract][Full Text] [Related]
17. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
18. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
[TBL] [Abstract][Full Text] [Related]
19. [BB creatine kinase isoenzyme activity in the blood serum of patients with senile dementia, Alzheimer's disease and schizophrenia].
Aksenova MV; Burbaeva GSh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):113-6. PubMed ID: 2609817
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study on histopathological findings between Alzheimer's disease and senile dementia of Alzheimer type].
Nakamura N
Rinsho Byori; 1996 Mar; 44(3):225-30. PubMed ID: 8857164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
